These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 4075093)

  • 1. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons.
    Clarke PB; Pert A
    Brain Res; 1985 Dec; 348(2):355-8. PubMed ID: 4075093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of cholecystokinin receptors in relation to the nigrostriatal and mesolimbic dopaminergic pathways.
    Gaudreau P; Quirion R; St-Pierre S; Chiueh CC; Pert A
    Neuropeptides; 1987; 9(4):283-93. PubMed ID: 3614556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic evidence for the localization of high affinity neurotensin binding sites on dopaminergic nerve terminals in the nigrostriatal and mesolimbic pathways in rat brain.
    Schotte A; Leysen JE
    J Chem Neuroanat; 1989; 2(5):253-7. PubMed ID: 2553068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals.
    Quirion R; Chiueh CC; Everist HD; Pert A
    Brain Res; 1985 Feb; 327(1-2):385-9. PubMed ID: 2985182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid binding sites in the nigrostriatal system of the guinea pig are not located on nigral dopaminergic neurons.
    Foote RW; Maurer R
    Neurosci Lett; 1986 Apr; 65(3):341-5. PubMed ID: 3012421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of chronic nicotine administration on dopaminergic receptor binding sites in rat nigrostriatal and mesolimbic regions.
    Fung YK; Lau YS
    Gen Pharmacol; 1991; 22(1):117-9. PubMed ID: 2050279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and opiate receptors: localization in the striatum and evidence for their axoplasmic transport in the nigrostriatal and striatonigral pathways.
    Van der Kooy D; Weinreich P; Nagy JI
    Neuroscience; 1986 Sep; 19(1):139-46. PubMed ID: 2431346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC; Crossman AR; Woodruff GN
    Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral modulation of [3H]neurotensin binding by unilateral intrastriatal 6-hydroxydopamine injections: evidence from a receptor autoradiographic study.
    Cadet JL; Kujirai K; Przedborski S
    Brain Res; 1991 Nov; 564(1):37-44. PubMed ID: 1663814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
    Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
    Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
    J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.
    Julou L; Scatton B; Glowinski J
    Adv Biochem Psychopharmacol; 1977; 16():617-24. PubMed ID: 18904
    [No Abstract]   [Full Text] [Related]  

  • 15. Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage.
    McCallum SE; Parameswaran N; Bordia T; McIntosh JM; Grady SR; Quik M
    Mol Pharmacol; 2005 Sep; 68(3):737-46. PubMed ID: 15933214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of serotonin-4 receptors in the striatonigral pathway in rat brain.
    Patel S; Roberts J; Moorman J; Reavill C
    Neuroscience; 1995 Dec; 69(4):1159-67. PubMed ID: 8848104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons.
    Kerkerian L; Salin P; Nieoullon A
    Neuroscience; 1988 Sep; 26(3):809-17. PubMed ID: 3143926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine depletion in nigrostriatal neurons in the genetically diabetic rat.
    Kono T; Takada M
    Brain Res; 1994 Jan; 634(1):155-8. PubMed ID: 8156386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation by nicotine of striatal neurons receiving excitatory input from the substantia nigra via dopamine release.
    Yu H; Matsubayashi H; Amano T; Cai J; Sasa M
    Brain Res; 2000 Jul; 872(1-2):223-6. PubMed ID: 10924698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M; Sjöholm B; Lappalainen J; Virtanen R
    Eur J Pharmacol; 1989 Oct; 169(2-3):321-4. PubMed ID: 2530097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.